Stock 455 TIANDA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Tianda Pharmaceuticals Limited

Equities

455

KYG887471038

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:20 26/04/2024 BST 		5-day change 1st Jan Change
0.265 HKD +3.92% Intraday chart for Tianda Pharmaceuticals Limited +1.92% +21.56%
03-26 Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-21 Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024
Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023
Tianda Pharmaceuticals Limited Announces Executive Changes, Effective 29 August 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023
Tianda Pharmaceuticals Limited Announces Board Changes
Tianda Pharmaceuticals Limited Approves Final Dividend
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Nine Months Ended 31 December 2022, Payable on or Before, 14 July 2023
Tianda Pharmaceuticals Unit to Invest HK$10 Million in Fund
Tianda Pharmaceuticals Limited Announces Final Ordinary Dividend for the Nine Months Ended 31 December 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Warns of Higher Loss in Fiscal Nine-Month Period; Shares Tumble 9%
Tianda Pharmaceuticals Limited Provides Group Earnings Guidance for the Nine Months Period from April 1, 2022 to December 31, 2022
Tianda Pharmaceuticals to Set Up Additional Production Line to Meet Rising Medicine Demand
Tianda Pharmaceuticals' Loss for Half Year Through September Narrows
Tianda Pharmaceuticals Limited Announces Changes in Financial Year End Date
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 455 Stock
  4. News Tianda Pharmaceuticals Limited
  5. Other languages